← Back to patent-cliff list
盐酸诺昔替林
Tier C — Watch / tradeNoxiptiline hydrochloride
-
Originator
2017
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：Not applicable
Indications (approved)：抑郁
Regional status
US
-
EU
批准上市
2017-11-27
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Noxiptiline hydrochloride?
Approved indications include: 抑郁.
When does the Noxiptiline hydrochloride patent expire?
No public expiry year is available for Noxiptiline hydrochloride yet; this page updates once verified.
How do I get a quote for Noxiptiline hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24